Sana Biotechnology, Inc.
SANA
$3.58
-$0.02-0.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -93.80M | -49.39M | -49.07M | -59.92M | -50.29M |
| Total Depreciation and Amortization | 2.86M | 3.65M | 3.80M | 4.06M | 3.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 61.21M | 7.94M | -6.17M | 4.39M | -14.49M |
| Change in Net Operating Assets | -3.37M | -10.86M | 4.27M | -344.00K | 2.35M |
| Cash from Operations | -33.10M | -48.66M | -47.16M | -51.82M | -58.54M |
| Capital Expenditure | 112.00K | -136.00K | -436.00K | -4.09M | -13.06M |
| Sale of Property, Plant, and Equipment | 382.00K | 253.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.19M | 16.49M | 47.52M | 45.87M | 18.87M |
| Cash from Investing | 7.68M | 16.60M | 47.09M | 41.78M | 5.82M |
| Total Debt Issued | -- | -- | -56.00K | 172.00K | 7.63M |
| Total Debt Repaid | -86.00K | -85.00K | -- | -- | -- |
| Issuance of Common Stock | 587.00K | 1.13M | 699.00K | 1.91M | 3.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 60.00K | -60.00K | -- | -- | -- |
| Cash from Financing | 561.00K | 982.00K | 643.00K | 2.08M | 10.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.86M | -31.07M | 570.00K | -7.96M | -42.10M |